Company Active LTD

Company profile

N4 Pharma UK Limited

Contact us - N4 Pharma

N4 Pharma UK Limited is a UK company with status active founded in 2014.

CRN
08878121
Founded
2014
Age
12

Overview

Legal name
N4 PHARMA UK LIMITED
Region
Unknown
Registered address
2 PORTMAN STREET
LONDON
UNITED KINGDOM
W1H 6DU
Insolvency history
No

Corporate ownership

Updated 06 Jun 2026 16:52

1 level 1 ultimate controller
1
Company Active LTD
N4 Pharma UK Limited
CRN 08878121
2
Direct and ultimate controller Active PLC
N4 Pharma PLC
CRN 01435584

Company events

Reference milestones and recent Companies House filing stream events.

5 events
12 Feb
2027

Confirmation statement due

Confirmation Due

Next confirmation statement due date

30 Sep
2026

Accounts due

Accounts Due

Next accounts due date

29 Jan
2026

Confirmation statement filed

Confirmation

Last confirmation statement made up date

31 Dec
2024

Accounts filed

Accounts

Last accounts made up date

05 Feb
2014

Incorporated

Inception

Company registered at Companies House

Public funding

2 awards
First funded
2017
Funded years
2017, 2018
Age at first award
2 years

Projects

2018 Feasibility Studies Lead participant

Manufacturing process development for Nuvec nanoparticles for the delivery of therapeutic Papilloma Virus (HPV) nucleic acid vaccines

1 Feb 2018 to 31 Oct 2018

Awarded
£44,405
Total cost £63,435

"Human Papilloma Virus (HPV) has been implicated in a range of cancers. Currently, a prophylactic vaccine is prescribed for adolescent girls with a view to prevent infection by HPV. However, this preventative vaccine does not have a therapeutic effect on malignancies developed as a result of HPV infection. In this regard, the use of nucleic acid vaccines ...

2017 Feasibility Studies Lead participant

NUVEC a platform technology for the vaccine delivery

1 Jan 2017 to 30 Nov 2017

Awarded
£118,509
Total cost £169,298

Nanotechnology platforms, including N4’s propriety NUVEC, are being investigated as vaccine carriers, adjuvants, and drug delivery systems. DNA vaccination indicates great potential for combating a variety of diseases including cancer. Safe and efficient delivery of plasmid DNA to initiate immune responses remains a major barrier in bringing DNA vaccinati...

Product types

Feasibility Studies